Overview
Carcinoma of the cheek, predominantly squamous cell carcinoma (Sq.c.c.), represents a significant oncologic challenge due to its aggressive nature and potential for extensive local invasion. This malignancy primarily affects adults, with risk factors including tobacco use, alcohol consumption, and chronic irritation. Given its location, tumors can lead to functional impairments such as speech difficulties and mastication issues, alongside aesthetic concerns. Proper management requires a multidisciplinary approach, integrating oncologic surgery, reconstructive techniques, and adjuvant therapies. Understanding the nuances of surgical reconstruction is crucial for clinicians to optimize patient outcomes, balancing oncologic safety with functional and aesthetic restoration 124.Pathophysiology
The development of cheek carcinoma typically originates from the squamous cells lining the oral mucosa. Chronic exposure to carcinogens, such as tobacco smoke and alcohol, induces genetic mutations leading to uncontrolled cell proliferation. These mutations often affect tumor suppressor genes (e.g., p53) and oncogenes (e.g., RAS), disrupting normal cell cycle regulation and promoting malignant transformation 4. At the cellular level, this results in dysplastic changes, invasion into deeper tissues, and potential lymphatic spread, contributing to the aggressive behavior observed clinically. The proximity of the cheek to critical structures necessitates careful surgical planning to preserve function and minimize complications 4.Epidemiology
Squamous cell carcinoma of the cheek has a relatively lower incidence compared to other oral cancers but remains a significant concern. Incidence rates vary geographically, with higher prevalence observed in regions with high tobacco and alcohol consumption. Typically, it affects older adults, with a median age at diagnosis often above 50 years. Males are disproportionately affected, with a male-to-female ratio ranging from 2:1 to 3:1. Over time, there has been a trend towards earlier detection due to improved screening practices, though overall incidence rates continue to rise in high-risk populations 4.Clinical Presentation
Patients with cheek carcinoma often present with non-specific symptoms initially, such as a persistent ulcer or mass that does not heal within two weeks. Common clinical features include:
Pain or discomfort in the affected area
Swelling or induration
Difficulty in chewing or swallowing
Changes in speech or facial asymmetry
Oral bleeding or discharge
Red-flag features that warrant urgent evaluation include rapid growth of the lesion, involvement of underlying structures, and signs of metastasis such as weight loss or lymphadenopathy. Early detection is crucial for better outcomes 4.Diagnosis
The diagnostic approach for cheek carcinoma involves a combination of clinical examination, imaging, and histopathological confirmation:
Clinical Examination: Detailed inspection and palpation to assess the extent and characteristics of the lesion.
Imaging: CT or MRI scans to evaluate local invasion and potential metastasis.
Biopsy: Definitive diagnosis through incisional or excisional biopsy, with histopathological examination confirming the presence of malignant squamous cells.Specific Criteria and Tests:
Biopsy Confirmation: Histological evidence of malignant squamous cells 4.
TNM Staging: Tumor size (T), nodal involvement (N), and distant metastasis (M) assessed via imaging and clinical examination 4.
Differential Diagnosis:
- Pyogenic Granuloma: Typically presents as a rapidly growing, soft, red, and sometimes bleeding mass.
- Oral Lichen Planus: Characterized by white striae and erosions, often with a more chronic course.
- Chronic Ulcer: May mimic carcinoma but lacks malignant cellular features on biopsy 4.Management
Surgical Resection
Primary Resection: Radical excision with adequate safety margins to ensure complete tumor removal 4.
Reconstructive Techniques:
- Modified Submandibular Angle Rotation Flap: Ideal for large perioral-cheek defects, offering stable closure and preserving lip mobility 1.
- Free Anterolateral Thigh Flap: Versatile for extensive through-and-through defects, providing adequate soft tissue coverage 2.
- Cross-Cheek Anterolateral Thigh Flap: Effective for complex defects involving trismus release and tumor ablation, minimizing the need for multiple flaps 3.Adjuvant Therapies
Radiotherapy: Post-surgical adjuvant treatment for high-risk features (e.g., positive margins, lymph node involvement) 4.
Chemotherapy: Considered in advanced stages or metastatic disease, often in combination with radiotherapy 4.Contraindications:
Severe comorbidities precluding major surgery or adjuvant therapies 4.Complications
Postoperative Complications: Flap necrosis, infection, fistula formation, and delayed wound healing.
Functional Impairments: Speech difficulties, mastication issues, and facial asymmetry.
Long-term Complications: Recurrence, secondary malignancies, and psychological impacts such as depression or anxiety.
Management Triggers: Early signs of infection (fever, purulent discharge), delayed healing (excessive swelling, non-healing wounds), and functional deficits requiring referral to specialized rehabilitation services 124.Prognosis & Follow-up
Prognosis for cheek carcinoma varies based on stage at diagnosis and completeness of resection. Key prognostic indicators include:
Tumor Stage: Early-stage (T1-T2) generally has better outcomes compared to advanced stages (T3-T4).
Lymph Node Involvement: Negative nodes correlate with improved survival rates.
Adjuvant Therapy Response: Effective adjuvant treatments can significantly enhance outcomes.Recommended Follow-up Intervals:
Initial Postoperative: Every 3-6 months for the first 2 years.
Long-term Monitoring: Annually thereafter, including clinical examination, imaging, and oral cavity screening 4.Special Populations
Elderly Patients
Considerations: Higher risk of comorbidities affecting surgical candidacy; tailored adjuvant therapy plans.
Management: Close monitoring for postoperative complications and functional recovery 4.Patients with Comorbidities
Cardiovascular Disease: Careful perioperative management to prevent cardiovascular events.
Renal Impairment: Dose adjustments for chemotherapy and monitoring for nephrotoxicity 4.Key Recommendations
Primary Surgical Resection with Adequate Margins: Ensure complete tumor removal to minimize recurrence risk (Evidence: Strong 4).
Reconstructive Surgery Using Versatile Flaps: Utilize flaps like the modified submandibular angle rotation flap or free anterolateral thigh flap for optimal functional and aesthetic outcomes (Evidence: Moderate 12).
Adjuvant Radiotherapy for High-Risk Features: Consider post-surgical radiotherapy for patients with positive margins, lymph node involvement, or advanced T-stage tumors (Evidence: Strong 4).
Comprehensive Follow-up Programs: Implement regular follow-up schedules including clinical exams and imaging to monitor for recurrence and manage long-term complications (Evidence: Moderate 4).
Multidisciplinary Team Approach: Engage oncologists, surgeons, and reconstructive specialists to tailor individualized treatment plans (Evidence: Expert opinion 4).
Screening and Early Detection: Promote regular oral cancer screenings, especially in high-risk populations (Evidence: Moderate 4).
Address Functional and Psychological Needs: Provide rehabilitation support and psychological counseling to address functional impairments and mental health concerns (Evidence: Expert opinion 4).
Tailored Management for Special Populations: Adjust treatment strategies considering comorbidities and age-related factors (Evidence: Expert opinion 4).
Monitor for Recurrence and Secondary Malignancies: Implement vigilant surveillance protocols to detect early signs of recurrence or new malignancies (Evidence: Moderate 4).
Educate Patients on Risk Factors: Inform patients about modifiable risk factors like tobacco and alcohol cessation to reduce recurrence risk (Evidence: Moderate 4).References
1 Lian C, Liu XJ, Zhang XF. One-Stage Reconstruction of a Large Perioral-Cheek Defect Using a Modified Submandibular Angle Rotation Flap. The Journal of craniofacial surgery 2026. link
2 Sun G, Lu M, Hu Q, Tang E. Reconstruction of extensive through-and-through cheek defects with free anterolateral thigh flap. The Journal of craniofacial surgery 2014. link
3 Chen CC, Wong TY, Ou CY, Lee JW. Using a cross-cheek anterolateral thigh flap for simultaneous correction of trismus and oral cancer. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2010. link
4 Denewer AT, Steet AE, Mohamed OH, Aly OF. Locally advanced cheek carcinoma; radical surgery and reconstruction of though and through defects. Journal of the Egyptian National Cancer Institute 2006. link